Tabla de contenido
Publicidad
Referencias
1.
Braunwald, E, et al. ACC/AHA 2002 guideline update for the management of patients with unstable
angina and non-ST-segment elevation myocardial infarction: a report of the American College
of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the
Management of Patients with Unstable Angina). 2002. Available at: http://www.acc.org/clinical/
guidelines/unstable/unstable.pdf.
2.
Antman EM, Tanasijevic, MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of
mortality in patients with acute coronary syndromes. NEJM 1996, 335(18): 1342-1349.
3.
Galvani M, Ottani F, Ferrini D, et al. Prognostic influence of elevated values of cardiac troponin I in
patients with unstable angina. Circulation 1997, 95: 2053-2059.
4.
Morrow DA, Rifai N, Tanasijevic MJ, et al. Clinical efficacy of three assays for cardiac troponin I for
risk stratification in acute coronary syndromes: A thrombolysis in myocardial infarction (TIMI) IIB
substudy. Clin Chem 2000, 46(4): 453-460.
5.
Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker approach to risk stratification in non-ST-
elevation acute coronary syndromes: Simultaneous assessment of troponin I, C-reactive protein, and
B-type natriuretic peptide. Circulation 2002, 105: 1760-1763.
6.
Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative
strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor
tirofiban. NEJM 2001, 344(25): 1879-1887.
7.
Morrow DA, Antman EM, Tanasijevic MJ, et al. Cardiac troponin I for stratification of early outcomes
and the efficacy of enoxaprin in unstable angina: A TIMI-IIB substudy. JACC 2000, 36: 1812-1817.
8.
Hamm CW, Heeschen C, Goldmann B, et al. Benefit of abciximab in patients with refractory unstable
angina in relation to serum troponin T levels (CAPTURE Study Investigators). NEJM 1999, 340: 1623-
1629.
9.
NCCLS. Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline - Second
Edition. NCCLS document EP9-A2 [ISBN 1-56238-472-4]. NCCLS, 940 West Valley Road, Suite 1400,
Wayne, Pennsylvania 19087-1898, USA 2002.
10. P.J. Cornbleet and N. Gochman, "Incorrect Least-Squares Regression Coefficients in Method-
Comparison Analysis," Clinical Chemistry 25:3, 432 (1979).
11 NCCLS. Interference Testing in Clinical Chemistry; Approved Guideline. NCCLS document EP7-A [ISBN
1-56238-480-5]. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA
2002.
Manufacturer:
i-STAT Corporation
104 Windsor Center Drive
East Windsor, NJ 08520
Tel: (609) 443-9300
Fax: (609) 443-9310
©2003 i-STAT Corporation. Reservados todos los derechos. Impreso en los EE.UU.
Emergo Europe
P.O. Box 18510
2502 EM The Hague
The Netherlands
USA
•
Tel: (31)70 345 8570
Fax: (31)70 346 7299
Art: 715595-04B
Rev. Date: 04/16/04
Publicidad
Tabla de contenido
